Understanding Sjögren's Syndrome

Sjögren's syndrome is an autoimmune disease where your immune system attacks the glands responsible for producing saliva and tears. The resulting severe xerostomia (dry mouth) and keratoconjunctivitis sicca (dry eyes) characterize the condition.

The disease affects approximately 0.5-1% of the population, with women affected 9 times more frequently than men. Onset typically occurs in middle-aged or older adults, though it can develop at any age.

The immune system produces autoantibodies (anti-SSA/Ro and anti-SSB/La) that attack the salivary and lacrimal glands. T-lymphocytes infiltrate these glands, causing progressive destruction of salivary acinar cells.

Pathophysiology and Gland Destruction

In Sjögren's syndrome, T cells attack and destroy the secretory epithelium of salivary glands. This progressive destruction leads to:

Fibrosis (scarring) of gland tissue
Reduced salivary acinar cells
Impaired salivary production
Complete or near-complete cessation of saliva production in severe cases

The process is irreversible—once destroyed, salivary gland tissue cannot regenerate. Early diagnosis and immune-suppressive therapy may slow but not reverse the progression.

Clinical Presentation: Oral Manifestations

Severe xerostomia is the hallmark oral manifestation. Patients describe:

Dry mouth, particularly at night
Difficulty chewing and swallowing without water
Tongue sticking to palate
Increased thirst
Mouth sores or fissures

Rapid cavity development occurs due to lack of saliva's protective antimicrobial and remineralizing properties. Cavities develop on tooth surfaces typically resistant to decay—outer surfaces, root surfaces, gingival margins.

Oral candidiasis (thrush) is common due to loss of saliva's antifungal properties.

Periodontal disease progresses rapidly without saliva's protective immunity.

Angular cheilitis (cracks at mouth corners) is common.

Difficulty wearing dentures develops due to lack of saliva for lubrication.

Altered taste and difficulty with speech may occur.

Severe cases may have difficulty eating enough to maintain nutrition.

Systemic Manifestations

Beyond the mouth, Sjögren's syndrome affects multiple organ systems:

Ocular (dry eyes): Xerophthalmia causes burning, grittiness, and vision blurring. Severe dry eyes can damage the cornea.

Rheumatologic: Arthritis, arthralgia, and myalgia occur in approximately 50% of patients.

Pulmonary: Interstitial lung disease, cough, and dyspnea occur in 20-40% of patients.

Renal: Kidney disease occurs in 20% of patients.

Hematologic: Lymphadenopathy (swollen lymph nodes) and anemia occur in 10-20% of patients.

Lymphoma: Patients with Sjögren's have increased risk of developing B-cell lymphomas.

Diagnostic Criteria and Testing

Diagnosis requires specific diagnostic criteria demonstrating both ocular and oral disease, along with serologic or histologic evidence of autoimmune disease.

Laboratory testing includes:

Serologic testing: Anti-SSA/Ro and anti-SSB/La antibodies (positive in 40-50% and 40-60% of patients respectively)
Rheumatoid factor: Elevated in 50-80%
ANA (antinuclear antibody): Elevated in 50-70%
Complete blood count: May show anemia

Ocular testing:

Schirmer test: Measures tear production
Rose Bengal or lissamine green staining: Assesses corneal damage

Salivary testing:

Salivary flow measurement: Reduced flow confirms severe xerostomia
Salivary composition analysis: Reduced protective proteins

Salivary gland imaging: Scintigraphy or MRI assesses gland damage.

Salivary gland biopsy: Shows characteristic lymphocytic infiltration and confirms diagnosis.

Primary Versus Secondary Sjögren's

Primary Sjögren's: Occurs without associated connective tissue disease. Affects salivary and lacrimal glands primarily.

Secondary Sjögren's: Occurs in patients with established rheumatoid arthritis, systemic lupus erythematosus, or other autoimmune diseases. Oral manifestations are similar but systemic disease is more extensive.

Management of Oral Manifestations

Saliva replacement remains foundational:

Saliva substitutes: Biotene and similar products provide lubrication and temporary symptom relief. Applied frequently throughout the day and especially before bed.

Salivary stimulants: Xylitol-based sugar-free gum or lozenges stimulate remaining salivary function.

Prescription saliva-stimulating medications: Pilocarpine (5 mg three times daily) and cevimeline (30 mg three times daily) enhance residual gland function. These work best in patients with some remaining salivary capacity.

Aggressive preventive dentistry is essential:

Professional fluoride treatments: High-concentration professional fluoride varnish at every dental visit provides intensive remineralization.

Home fluoride therapy: Prescription 5000 ppm toothpaste and nightly fluoride gel application (custom tray) are necessary.

Professional cleaning: Quarterly or more frequent cleanings remove plaque before it mineralizes to calculus.

Antimicrobial therapy: Prescription antimicrobial rinses reduce cavity-causing bacteria.

Antifungal therapy: Preventive antifungal therapy (nystatin or fluconazole) prevents thrush development.

Dietary counseling: Eliminate fermentable carbohydrates and acidic beverages that damage teeth in xerostomic patients.

Systemic Immune Suppression

Systemic disease management aims to slow progression and manage associated organ involvement:

Hydroxychloroquine: Often the first-line systemic treatment. Improves both exocrine (salivary, tear) and systemic symptoms.

NSAIDs: Reduce inflammatory symptoms and pain.

Corticosteroids: Used for systemic manifestations and severe glandular disease.

Immunosuppressive agents: Methotrexate, mycophenolate mofetil, or rituximab (B-cell depleting therapy) are used for progressive disease with significant systemic involvement.

Patient Education and Lifestyle Modification

Increased water consumption: Sip frequently throughout the day. Many patients keep water constantly available.

Environmental humidity: Humidifiers reduce evaporative moisture loss from mouth during sleep.

Avoid salivary suppressants: Alcohol, caffeine, antihistamines, and tobacco suppress salivary function further.

Moisture-promoting foods: Choose moist, soft foods requiring less chewing.

Avoid irritating foods: Spicy, acidic, hot, and dry foods are difficult to manage without adequate saliva.

Smoking cessation: Tobacco exacerbates dry mouth and increases infection risk.

Dental Care Coordination

Your dentist should know about your Sjögren's diagnosis to:

Intensify preventive care appropriately
Modify treatment plans (avoid certain materials that dry mouth exacerbates)
Monitor for complications (candidiasis, rapid caries)

Rheumatology coordination ensures systemic management isn't overlooked.

Prognosis and Long-Term Outlook

Sjögren's syndrome is progressive and incurable with current therapies. Immune suppression can slow but not reverse gland destruction.

Salivary function continues to decline over years, requiring escalating intervention intensity.

However, with aggressive preventive dental care and systemic management, patients maintain functional dentition and quality of life.

Early diagnosis and initiation of immune-suppressive therapy may slow systemic progression and preserve more salivary function than delayed treatment.

If you experience persistent dry mouth and dry eyes, discuss evaluation for Sjögren's syndrome with your physician. Early diagnosis and aggressive dental management prevent the severe dental consequences of untreated Sjögren's.